News
- 当社団理事 竹政伊知朗が国産初の手術支援ロボット「hinotoriTM」 による大腸癌手術を行いました
- 第9回産官学がんゲノム医療最前線意見交換会の参加申込みを開始いたしました！
- e-Precision Medicine Japanをお使いの皆様へ重要なお知らせ
- 個人会員制度を開始いたしました！
- TBSラジオ【ミヤリサン製薬 プレゼンツ 腸から始まる健康ライフ】に当社団理事が出演しております！
- Dr. Oki, Director of 22CEMIT, appeared on TV program, "Sunday News THE PRIME" (Fuji Television Network)!
- Dr. Yoshino, chairman of 22CEMIT, became the first Japanese to give a presentation at the Plenary Session of ASCO2022!
- Takayuki Yoshino, chairman of 22CEMIT, has been appointed as deputy director (Research) of the National Cancer Center Hospital East.
- Dr. Takayuki Yoshino spoke at the LDP's special committee!
- Dr. Takemasa, Director of 22 CEMIT, appeared on TV program, "The HUMAN - Envolving Surgeon"
- The 8th Opinion Exchange Meeting on the Forefront of Industry-Government-Academia Cancer Genome Medicine will be held! (Saturday, May 7, 2022 09:00-13:00)
- Dr. Yoshino, chairman of 22CEMIT, appeared on TV program, "Kyou-no-Kenko (Health Today)".
- Dr. Yoshino, chairman of 22CEMIT, was nominated as the first Japanese member of the Executive Board, which oversees ICGC-ARGO.
- The 1st Cancer CRC Study Group Meeting will be held.
- The 6th Opinion Exchange Meeting on the Forefront of Industry-Government-Academia Cancer Genome Medicine was held.
- Dr. Yoshino, chairman of 22CEMIT and Chief of Gastrointestinal Medicine at National Cancer Center East Hospital, has been introduced in a special program on TV Tokyo and BS TV Tokyo on his efforts in cutting-edge cancer treatment.
- CIRCULATE-Japan project led by Dr. Yoshino, chairman of 22CEMIT and Chief of Gastrointestinal Medicine at National Cancer Center East Hospital, was introduced in Shukan Shincho.
- The 5th Opinion Exchange Meeting on the Forefront of Industry-Government-Academia Cancer Genome Medicine was held.
- Research paper by the research group led by Dr. Yoshino, chairman of 22CEMIT, was published in "Nature Medicine".
- Dr.Yoshino, chairman of 22CEMIT, has started the world's largest investigator-initiated trial.
- Interview featuring Dr.Yoshino, chairman of 22CEMIT, has been published in Microsoft's medical website.
- Interview featuring Dr. Yoshino, chairman of 22CEMIT, has been published in BEST DOCTORS IN JAPAN.
- The technology developed by Natera Inc "To judge the possibility of cancer recurrence at 90% accuracy" has been invterviewd by TV Asahi Corporation.
- Cancer Genomic Medical Online Course is now available at Docomo gacco
- Dr. Kentaro Yamazaki, director of 22CEMIT, has received the Annals of Oncology Award 2019.
- 22CEMIT cooperated in publishing “Handbook of Hereditary Cancer” (published from KANEHARA & CO., LTD. )
- 22CEMIT Chairman & CEO, Takayuki Yoshino, spoke at Google Cloud Next ’19 | San Francisco on “Virtual Sequencing”.
- National Cancer Center Hospital East transferred management of ”e-Precision Medicine Japan” educational website to 22CEMIT.
- 22CEMIT hosted a VR conference of oncologists.
English 
Japanese